Hayward, CA, United States of America

Alban R Pereira-Badilla


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alban R Pereira-Badilla: Innovator in Pharmaceutical Compounds

Introduction

Alban R Pereira-Badilla is a notable inventor based in Hayward, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit proteases. His work is crucial in addressing various medical conditions, including viral infections and cancers.

Latest Patents

Alban R Pereira-Badilla holds a patent for "Compositions and methods for inhibiting proteases." This invention provides pharmaceutical compounds and formulations that include a family of epoxyketone compounds. These compounds can be administered to individuals to treat, prevent, reverse, or ameliorate infections, diseases, or conditions that can be addressed by inhibiting protease activity. The patent specifically mentions applications in treating retroviral infections such as HIV-1, immune disorders, neurodegenerative diseases, and various types of cancer.

Career Highlights

Alban is affiliated with the University of California, where he continues to engage in research and development of innovative pharmaceutical solutions. His work has the potential to impact the treatment of serious health conditions, making him a valuable asset in the scientific community.

Collaborations

Alban has collaborated with notable colleagues, including William H Gerwick and Tara Byrum. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Alban R Pereira-Badilla is a distinguished inventor whose work in pharmaceutical compounds demonstrates the importance of innovation in medicine. His contributions are vital for developing treatments for various diseases and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…